Cover Image
市場調查報告書

視網膜中心靜脈閉塞症:全球臨床實驗趨勢

Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 338375
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
視網膜中心靜脈閉塞症:全球臨床實驗趨勢 Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016
出版日期: 2016年12月21日 內容資訊: 英文 83 Pages
簡介

本報告提供視網膜中心靜脈閉塞症臨床實驗最新趨勢相關分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 視網膜中心靜脈閉塞症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上視網膜中心靜脈閉塞症的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上視網膜中心靜脈閉塞症的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

視網膜中心靜脈閉塞症治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • F. Hoffmann-La Roche Ltd.
    • Regeneron Pharmaceuticals, Inc.
    • Bayer AG
    • Allergan Plc
    • Mid Atlantic Retina
    • Jaguar Holding Company II
    • Gene Signal International SA
    • California Retina Consultants
    • Asociacion para Evitar la Ceguera en Mexico I.A.P.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Shahid Beheshti University of Medical Sciences
    • Banco de Olhos de Sorocaba
    • Centre Hospitalier Intercommunal Creteil
    • Duke University
    • Eye Laser Surgery Center
    • Gazi University
    • Glostrup University Hospital
    • Greater Houston Retina Research
    • Het Oogziekenhuis Rotterdam
    • IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4011CTIDB

GlobalData's clinical trial report, "Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016" provides an overview of Central Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to the clinical trials on Central Retinal Vein Occlusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Central Retinal Vein Occlusion Therapeutics Clinical Trials 26
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 80

  • Abbreviations 80
  • Definitions 80
  • Research Methodology 81
  • Secondary Research 81
  • About GlobalData 82
  • Contact Us 82
  • Disclaimer 82
  • Source 83

List of Tables

List of Tables

  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
  • Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
  • Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
  • Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase, 2016* 19
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures

List of Figures

  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
  • Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
  • Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
  • Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
  • Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
  • Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
  • GlobalData Methodology 81
Back to Top